Status:

COMPLETED

The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection

Lead Sponsor:

Sisli Hamidiye Etfal Training and Research Hospital

Conditions:

Covid19

Smoking

Eligibility:

All Genders

18+ years

Brief Summary

This is a retrospective single centered study that was done in the ICU on patients with Covid-19 between 16th of March -16th of May in 2020 Retrospective records will be examined by examining the elec...

Detailed Description

The aims of the present study is to see the effects of smoking prevalence, the length of stay regarding the usage of cigarettes, and the effects on the mortality of COVID-19 in our intensive care unit...

Eligibility Criteria

Inclusion

  • All the patient's data are diagnosed with acute respiratory syndrome Covid-19 over 18 years old

Exclusion

  • Patients under 18 years of age

Key Trial Info

Start Date :

March 15 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 30 2020

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04874363

Start Date

March 15 2020

End Date

May 30 2020

Last Update

May 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sisli Hamidiye Etfal Research and Training Hospital

Istanbul, Turkey (Türkiye)

The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection | DecenTrialz